{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:34:34Z","timestamp":1791858874727,"version":"4.3.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Inherited cancer syndromes are caused by genetic mutations that place patients at an increased risk for developing cancer. Although most cancers are not caused by genetic inheritance, clinicians must understand these syndromes and be able to recognize their common characteristics. A thorough family history and identification of common patterns as well as specific clinical signs and symptoms can help with early recognition. This article describes symptoms of the more common cancer syndromes, including hereditary breast and ovarian cancer, Li-Fraumeni, Lynch, familial adenomatous polyposis, retinoblastoma, multiple endocrine neoplasia, and von Hippel-Lindau. Important patient education regarding genetic testing also is covered.<\/jats:p>","DOI":"10.1097\/01.jaa.0000721648.46099.2c","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T02:55:05Z","timestamp":1605927305000},"page":"10-16","source":"Crossref","is-referenced-by-count":18,"title":["A review of inherited cancer susceptibility syndromes"],"prefix":"10.1097","volume":"33","author":[{"given":"Gina R.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wentling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey A.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"38","key":"R1-20230817","first-page":"1","article-title":"Concise handbook of familial cancer susceptibility syndromes - second edition","author":"Lindor","year":"2008","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"9","key":"R2-20230817","first-page":"826","article-title":"When to suspect a genetic syndrome","volume":"86","author":"Solomon","year":"2012","journal-title":"Am Fam Physician"},{"issue":"41","key":"R3-20230817","first-page":"706","article-title":"Hereditary cancer syndromes","volume":"105","author":"Rahner","year":"2008","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"R8-20230817","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1634\/theoncologist.2012-0452","article-title":"BRCA1\/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management","volume":"18","author":"Lindor","year":"2013","journal-title":"Oncologist"},{"issue":"10","key":"R9-20230817","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GIM.0b013e3181ac9aea","article-title":"PTEN hamartoma tumor syndrome: an overview","volume":"11","author":"Hobert","year":"2009","journal-title":"Genet Med"},{"issue":"2","key":"R10-20230817","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","article-title":"Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors","volume":"21","author":"Riley","year":"2012","journal-title":"J Genet Couns"},{"issue":"5","key":"R11-20230817","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jso.21856","article-title":"Translational advances regarding hereditary breast cancer syndromes","volume":"105","author":"Gage","year":"2012","journal-title":"J Surg Oncol"},{"issue":"12","key":"R12-20230817","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"R13-20230817","first-page":"171","article-title":"A new paradigm of genetic testing for hereditary breast\/ovarian cancers","volume":"22","author":"Kwong","year":"2016","journal-title":"Hong Kong Med J"},{"issue":"6","key":"R14-20230817","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1542-2011.2012.00199.x","article-title":"An overview of hereditary breast and ovarian cancer syndrome","volume":"57","author":"Smith","year":"2012","journal-title":"J Midwifery Womens Health"},{"issue":"2","key":"R16-20230817","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.soncn.2015.02.007","article-title":"Genetic tests to identify risk for breast cancer","volume":"31","author":"Lynch","year":"2015","journal-title":"Semin Oncol Nurs"},{"issue":"8","key":"R19-20230817","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","article-title":"Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J Clin Oncol"},{"issue":"21","key":"R20-20230817","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"R21-20230817","first-page":"1932","article-title":"P53 germline mutations in childhood cancers and cancer risk for carrier individuals","volume":"82","author":"Chompret","year":"2000","journal-title":"Br J Cancer"},{"key":"R22-20230817","article-title":"Li-Fraumeni syndrome","author":"Schneider","journal-title":"GeneReviews"},{"issue":"6","key":"R23-20230817","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"issue":"1","key":"R24-20230817","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/gim.2013.166","article-title":"ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)","volume":"16","author":"Hegde","year":"2014","journal-title":"Genet Med"},{"issue":"2","key":"R26-20230817","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer","volume":"147","author":"Giardiello","year":"2014","journal-title":"Gastroenterology"},{"issue":"22","key":"R27-20230817","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"R29-20230817","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"R30-20230817","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MEG.0000000000000010","article-title":"Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update","volume":"26","author":"Aihara","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10 Online","key":"R31-20230817","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/j.1463-1318.2010.02218.x","article-title":"Attenuated familial adenomatous polyposis: results from an international collaborative study","volume":"12","author":"Knudsen","year":"2010","journal-title":"Colorectal Dis"},{"issue":"4","key":"R32-20230817","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ddmec.2008.05.004","article-title":"Inheritance of colorectal cancer","volume":"4","author":"Burt","year":"2007","journal-title":"Drug Discov Today Dis Mech"},{"issue":"26","key":"R33-20230817","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"R34-20230817","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.semdp.2015.10.007","article-title":"Retinoblastoma: an update","volume":"33","author":"Delhiwala","year":"2016","journal-title":"Semin Diagn Pathol"},{"issue":"38","key":"R35-20230817","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/sj.onc.1209622","article-title":"Diagnosis and current management of retinoblastoma","volume":"25","author":"Balmer","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"R36-20230817","first-page":"103","article-title":"Epidemiology and Rb1 gene of retinoblastoma","volume":"4","author":"Yun","year":"2011","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"R38-20230817","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(01)00713-8","article-title":"Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma","volume":"108","author":"Abramson","year":"2001","journal-title":"Ophthalmology"},{"key":"R40-20230817","doi-asserted-by":"crossref","first-page":"705036","DOI":"10.1155\/2012\/705036","article-title":"Genetic and clinical features of multiple endocrine neoplasia types 1 and 2","volume":"2012","author":"Romei","year":"2012","journal-title":"J Oncol"},{"issue":"9","key":"R41-20230817","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"issue":"7","key":"R42-20230817","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol"},{"issue":"12","key":"R43-20230817","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9374","key":"R45-20230817","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R47-20230817","doi-asserted-by":"crossref","first-page":"909121","DOI":"10.5402\/2011\/909121","article-title":"Mutation analysis of the APC gene in a Chinese FAP pedigree with unusual phenotype","volume":"2011","author":"Chen","year":"2011","journal-title":"ISRN Gastroenterol"},{"issue":"4","key":"R48-20230817","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/pbc.24280","article-title":"Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience","volume":"60","author":"Friedman","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"R49-20230817","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J Med Genet"},{"issue":"9363","key":"R50-20230817","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(03)12856-5","article-title":"Prediction of pathogenic mutations in patients with early-onset breast cancer by family history","volume":"361","author":"Lalloo","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"R51-20230817","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"R52-20230817","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":"Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations","volume":"75","author":"Barrow","year":"2009","journal-title":"Clin Genet"},{"issue":"7","key":"R53-20230817","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/gut.2004.053843","article-title":"Prevention and management of duodenal polyps in familial adenomatous polyposis","volume":"54","author":"Brosens","year":"2005","journal-title":"Gut"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000721648.46099.2c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:25:17Z","timestamp":1697163917000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000721648.46099.2c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000721648.46099.2c","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}